3.9 Article

Mitochondrial Retinopathy

Journal

OPHTHALMOLOGY RETINA
Volume 6, Issue 1, Pages 65-79

Publisher

ELSEVIER INC
DOI: 10.1016/j.oret.2021.02.017

Keywords

Autofluorescence; Genetics; Mitochondrial disease; OCT; Retinal imaging

Categories

Funding

  1. Dr. Werner Jackstadt Foundation, Wuppertal, Germany [S0134-10.22]
  2. Bayer Global Ophthalmology Awards Program
  3. National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC)
  4. Chiesi Farmaceutici, Parma, Italy
  5. German Federal Ministry of Education and Research [01GM1906E]

Ask authors/readers for more resources

By studying the retinal phenotype and associated genetic and systemic findings in patients with mitochondrial disease, researchers found that different types of mitochondrial retinopathy exhibit characteristic features. Recognizing these features can facilitate the earlier diagnosis of mitochondrial disease, particularly in patients with mild or nebulous multisystem disease.
Purpose: To report the retinal phenotype and the associated genetic and systemic findings in patients with mitochondrial disease. Design: Retrospective case series. Participants: Twenty-three patients with retinopathy and mitochondrial disease, including chronic progressive external ophthalmoplegia (CPEO), maternally inherited diabetes and deafness (MIDD), mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), Kearns-Sayre syndrome, neuropathy, ataxia, and retinitis pigmentosa (NARP) syndrome, and other systemic manifestations. Methods: Review of case notes, retinal imaging, electrophysiologic assessment, molecular genetic testing including protein modeling, and histologic analysis of muscle biopsy. Main Outcome Measures: Phenotypic characteristics of mitochondrial retinopathy. Results: Genetic testing identified sporadic large-scale mitochondrial DNA deletions and variants in MT-TL1, MT-ATP6, MT-TK, MT-RNR1, or RRM2B. Based on retinal imaging, 3 phenotypes could be differentiated: type 1 with mild, focal pigmentary abnormalities; type 2 characterized by multifocal white-yellowish subretinal deposits and pigment changes limited to the posterior pole; and type 3 with widespread granular pigment alterations. Advanced type 2 and 3 retinopathy presented with chorioretinal atrophy that typically started in the peripapillary and paracentral areas with foveal sparing. Two patients exhibited a different phenotype: 1 revealed an occult retinopathy, and the patient with RRM2B-associated retinopathy showed no foveal sparing, no severe peripapillary involvement, and substantial photoreceptor atrophy before loss of the retinal pigment epithelium. Two patients with type 1 disease showed additional characteristics of mild macular telangiectasia type 2. Patients with type 1 and mild type 2 or 3 disease demonstrated good visual acuity and no symptoms associated with the retinopathy. In contrast, patients with advanced type 2 or 3 disease often reported vision problems in dim light conditions, reduced visual acuity, or both. Short-wavelength autofluorescence usually revealed a distinct pattern, and near-infrared autofluorescence may be severely reduced in type 3 disease. The retinal phenotype was key to suspecting mitochondrial disease in 11 patients, whereas 12 patients were diagnosed before retinal examination. Conclusions: Different types of mitochondrial retinopathy show characteristic features. Even in absence of visual symptoms, their recognition may facilitate the often challenging and delayed diagnosis of mitochondrial disease, in particular in patients with mild or nebulous multisystem disease. (C) 2021 by the American Academy of Ophthalmology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available